Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2799-2802, December 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maurice, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maurice, P. A.

Release of Thymidine from X-irradiated Spleen in the Rabbit as Determined by a New Bioassay1

Pierre A. Maurice2

Departments of Medicine A and Experimental Therapeutics, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14203, and Onco-hematology Unit, Department of Medicine, University Hospital, 1205 Geneva, Switzerland

Plasma collected from the spleen of rabbits 2 to 4 hr after selective splenic irradiation decreased from 75 to 95% the uptake of 125I-labeled 5-iodo-2'-deoxyuridine by a suspension of bone marrow cells from untreated rabbits. The factor responsible for the decreased uptake was found to be dialyzable and, on paper chromatography in 4 different solvent systems, had the same RF values as did thymidine. Serial dilutions of this factor gave a dose-related response in the bone marrow suspensions that was identical to that obtained with thymidine, 0.01 to 0.25 µg/ml, confirming the chromatographic identification of the plasma factor as thymidine. The extent of thymidine release as measured by this sensitive method may be useful in evaluating early cell damage following X-irradiation.

1 Supported by Research Grants CA-5834 and CA-12585 from the NIH, USPHS, and by Grants 3.114.69 and 3.386.70 from the Fonds National Suisse de la Recherche Scientifique.

2 Present Address: Centre d'Onco-hematologie, Hôpital Cantonal, 1205 Geneva, Switzerland.

Received 6/12/72. Accepted 9/13/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.